Laboratory Medicine ›› 2026, Vol. 41 ›› Issue (10): 1022-1029.DOI: 10.3969/j.issn.1673-8640.2026.10.014
Previous Articles Next Articles
FU Xiaomei, JIN Weifeng, LI Dan, CHEN Shuzi, LI Zhenhua, MA Peijun, LIN Ping(
)
Received:2025-05-13
Revised:2025-12-30
Online:2026-10-30
Published:2026-10-20
CLC Number:
FU Xiaomei, JIN Weifeng, LI Dan, CHEN Shuzi, LI Zhenhua, MA Peijun, LIN Ping. Research progress on exosome-derived biomarkers of schizophrenia[J]. Laboratory Medicine, 2026, 41(10): 1022-1029.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2026.10.014
| 名称 | 表达 变化 | 样本来源 | 检测方法 | 研究对象 | 可能涉及的机制 | 参考文献 |
|---|---|---|---|---|---|---|
| ncRNA | ||||||
| miR-497 | 上调 | 脑组织① | qPCR② | SCZ患者8例、健康对照者13名 | 未提及 | [ |
| miR-223 | 上调 | 脑眶额叶皮质① | RT-qPCR | SCZ患者29例、健康对照者25名 | 谷氨酸受体功能减退,神经炎症 | [ |
| miR-206 | 上调 | 血清 | RT-qPCR | 训练集:23/23 测试集:23/23 技术验证:SCZ患者100、健康对照者 100名 | 调节BDNF | [ |
| miR-675 | 上调 | 血浆 | qPCR | SCZ患者9例、健康对照者9名 | MEF2C功能缺陷,神经炎症 | [ |
| miR-137 | 上调 | 血浆 | RT-qPCR | SCZ患者138例、健康对照者134名 | 氧化应激 | [ |
| chr3_196488683_ 196483770_-4913等 | 上调 | 血浆 | RT-qPCR | 发现队列:SCZ患者5例、健康对照者5名 验证队列:SCZ患者6例、健康对6名 | DNA损伤,组蛋白泛素化,应激反应 | [ |
| chr15:93496587-93499879+ -hsa-miR-20b-5p-ANK网络等 | 未提及 | 血浆 | RT-qPCR | 发现队列:SCZ患者10例、健康对照者 10名 验证队列:SCZ患者31例、健康对照者 31名 | 神经发育,突触功能 | [ |
| MIAT、PVT1 | 未提及 | 血清 | RT-qPCR | SCZ患者56例、健康对照者96名 | 未提及 | [ |
| ENSG00000251562-miR-26a-5p-EZH2网络 | 未提及 | 血浆 | 高通量测序 | SCZ患者10例、健康对照者10名 | 中枢神经系统增殖和分化调控 | [ |
| ENSG00000251562-miR-22-3p-SIRT1网络 | 未提及 | 血浆 | 高通量测序 | SCZ患者10例、健康对照者10名 | 多巴胺能信号通路 | [ |
| 蛋白 | ||||||
| MFN2、CYPD、humanin、MOTS-c | 下调 | 血浆、ADEV和NDEV | ELISA③ | SCZ患者10例、健康对照者10名 | 线粒体功能障碍、神经元损伤和代谢紊乱 | [ |
| SNPH | 上调 | ELISA | SCZ患者10例、健康对照者10名 | 线粒体功能异常 | [ | |
| LETM1、TRPM4、NCLX | 下调 | 血浆、NDEV | ELISA | SCZ患者10例、健康对照者10名 | 线粒体钙离子调控网络异常 | [ |
| CACNA-1C | 上调 | ELISA | SCZ患者10例、健康对照者10名 | 线粒体钙离子调控网络异常 | [ | |
| C3、C4、C4PBA、PROS1 | 上调 | 血浆 | ELISA | SCZ患者100例、健康对照者149名 | 补体系统异常 | [ |
| P-T181-Tau蛋白、 Aβ42 | 上调 | 血浆、ADE | ELISA | SCZ患者60例、健康对照者60名 | 氧化应激 | [ |
| HSP90AA1、PSMB1、PSMB2 | 上调 | 血浆 | 蛋白质组学 | SCZ患者15例、健康对照者45名 | 神经炎症,泛素-蛋白酶体通路异常 | [ |
| GFAP | 上调 | 血浆 | 免疫印迹法 | SCZ患者24例、健康对照者12名 | 神经炎症 | [ |
| α-II血影蛋白 | 下调 | 血浆 | 免疫印迹法 | SCZ患者24例、健康对照者12名 | 神经元异常 | [ |
| FN1、ITGB3、PECAM1、ITGA6、CD5 | 上调/下调 | 血浆 | 高通量单外泌体表面蛋白分析 | SCZ患者50例、健康对照者10名 | 内皮功能障碍,神经发育异常等 | [ |
| 脂质及代谢物 | ||||||
| Cer(d18:0/24:1)等 | 上调/下调 | 血清 | 超高效液相色谱-串联质谱 | SCZ患者20例、健康对照者20名 | 脂质代谢 | [ |
| L-精氨酸等 | 上调/下调 | 血清 | 超高效液相色谱-串联质谱 | 训练集:SCZ患者79例、健康对照者66名; 3个测试集:SCZ患者107例、健康对照者62名;SCZ患者104例、健康对照者142名;SCZ患者96例、健康对照者62名 | 甘油磷脂代谢 | [ |
| 名称 | 表达 变化 | 样本来源 | 检测方法 | 研究对象 | 可能涉及的机制 | 参考文献 |
|---|---|---|---|---|---|---|
| ncRNA | ||||||
| miR-497 | 上调 | 脑组织① | qPCR② | SCZ患者8例、健康对照者13名 | 未提及 | [ |
| miR-223 | 上调 | 脑眶额叶皮质① | RT-qPCR | SCZ患者29例、健康对照者25名 | 谷氨酸受体功能减退,神经炎症 | [ |
| miR-206 | 上调 | 血清 | RT-qPCR | 训练集:23/23 测试集:23/23 技术验证:SCZ患者100、健康对照者 100名 | 调节BDNF | [ |
| miR-675 | 上调 | 血浆 | qPCR | SCZ患者9例、健康对照者9名 | MEF2C功能缺陷,神经炎症 | [ |
| miR-137 | 上调 | 血浆 | RT-qPCR | SCZ患者138例、健康对照者134名 | 氧化应激 | [ |
| chr3_196488683_ 196483770_-4913等 | 上调 | 血浆 | RT-qPCR | 发现队列:SCZ患者5例、健康对照者5名 验证队列:SCZ患者6例、健康对6名 | DNA损伤,组蛋白泛素化,应激反应 | [ |
| chr15:93496587-93499879+ -hsa-miR-20b-5p-ANK网络等 | 未提及 | 血浆 | RT-qPCR | 发现队列:SCZ患者10例、健康对照者 10名 验证队列:SCZ患者31例、健康对照者 31名 | 神经发育,突触功能 | [ |
| MIAT、PVT1 | 未提及 | 血清 | RT-qPCR | SCZ患者56例、健康对照者96名 | 未提及 | [ |
| ENSG00000251562-miR-26a-5p-EZH2网络 | 未提及 | 血浆 | 高通量测序 | SCZ患者10例、健康对照者10名 | 中枢神经系统增殖和分化调控 | [ |
| ENSG00000251562-miR-22-3p-SIRT1网络 | 未提及 | 血浆 | 高通量测序 | SCZ患者10例、健康对照者10名 | 多巴胺能信号通路 | [ |
| 蛋白 | ||||||
| MFN2、CYPD、humanin、MOTS-c | 下调 | 血浆、ADEV和NDEV | ELISA③ | SCZ患者10例、健康对照者10名 | 线粒体功能障碍、神经元损伤和代谢紊乱 | [ |
| SNPH | 上调 | ELISA | SCZ患者10例、健康对照者10名 | 线粒体功能异常 | [ | |
| LETM1、TRPM4、NCLX | 下调 | 血浆、NDEV | ELISA | SCZ患者10例、健康对照者10名 | 线粒体钙离子调控网络异常 | [ |
| CACNA-1C | 上调 | ELISA | SCZ患者10例、健康对照者10名 | 线粒体钙离子调控网络异常 | [ | |
| C3、C4、C4PBA、PROS1 | 上调 | 血浆 | ELISA | SCZ患者100例、健康对照者149名 | 补体系统异常 | [ |
| P-T181-Tau蛋白、 Aβ42 | 上调 | 血浆、ADE | ELISA | SCZ患者60例、健康对照者60名 | 氧化应激 | [ |
| HSP90AA1、PSMB1、PSMB2 | 上调 | 血浆 | 蛋白质组学 | SCZ患者15例、健康对照者45名 | 神经炎症,泛素-蛋白酶体通路异常 | [ |
| GFAP | 上调 | 血浆 | 免疫印迹法 | SCZ患者24例、健康对照者12名 | 神经炎症 | [ |
| α-II血影蛋白 | 下调 | 血浆 | 免疫印迹法 | SCZ患者24例、健康对照者12名 | 神经元异常 | [ |
| FN1、ITGB3、PECAM1、ITGA6、CD5 | 上调/下调 | 血浆 | 高通量单外泌体表面蛋白分析 | SCZ患者50例、健康对照者10名 | 内皮功能障碍,神经发育异常等 | [ |
| 脂质及代谢物 | ||||||
| Cer(d18:0/24:1)等 | 上调/下调 | 血清 | 超高效液相色谱-串联质谱 | SCZ患者20例、健康对照者20名 | 脂质代谢 | [ |
| L-精氨酸等 | 上调/下调 | 血清 | 超高效液相色谱-串联质谱 | 训练集:SCZ患者79例、健康对照者66名; 3个测试集:SCZ患者107例、健康对照者62名;SCZ患者104例、健康对照者142名;SCZ患者96例、健康对照者62名 | 甘油磷脂代谢 | [ |
| [1] |
Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China:a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3):211-224.
DOI URL |
| [2] |
Tandon R, Nasrallah H, Akbarian S, et al. The schizophrenia syndrome,circa 2024:what we know and how that informs its nature[J]. Schizophr Res, 2024, 264:1-28.
DOI URL |
| [3] |
Krylova S V, Feng D. The machinery of exosomes:biogenesis,release,and uptake[J]. Int J Mol Sci, 2023, 24(2):1337.
DOI URL |
| [4] |
Satao K S, Doshi G M. Intercellular communication via exosomes:a new paradigm in the pathophysiology of neurodegenerative disorders[J]. Life Sci, 2025, 365:123468.
DOI URL |
| [5] |
Dwivedi M, Ghosh D, Saha A, et al. Biochemistry of exosomes and their theranostic potential in human diseases[J]. Life Sci, 2023, 315:121369.
DOI URL |
| [6] |
田泽, 刘宏瑞, 司文喆. 外泌体微小RNA作为肝细胞肝癌生物标志物的研究进展[J]. 检验医学, 2025, 40(4):317-323.
DOI |
| [7] |
Du Y, Tan W L, Chen L, et al. Exosome transplantation from patients with schizophrenia causes schizophrenia-relevant behaviors in mice:an integrative multi-omics data analysis[J]. Schizophr Bull, 2021, 47(5):1288-1299.
DOI URL |
| [8] |
Xie M, Zhang Y, Yan L, et al. Peripheral blood non-coding RNA as biomarker for schizophrenia:a review[J]. J Integr Neurosci, 2024, 23(2):42.
DOI URL |
| [9] |
Khoodoruth M A S, Khoodoruth W N C, Uroos M, et al. Diagnostic and mechanistic roles of microRNAs in neurodevelopmental & neurodegenerative disorders[J]. Neurobiol Dis, 2024, 202:106717.
DOI URL |
| [10] |
Banigan M G, Kao P F, Kozubek J A, et al. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients[J]. PLoS One, 2013, 8(1):e48814.
DOI URL |
| [11] |
Amoah S K, Rodriguez B A, Logothetis C N, et al. Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics[J]. Neuropsychopharmacology, 2020, 45(4):656-665.
DOI PMID |
| [12] |
Du Y, Yu Y, Hu Y, et al. Genome-wide,integrative analysis implicates exosome-derived microrna dysregulation in schizophrenia[J]. Schizophr Bull, 2019, 45(6):1257-1266.
DOI URL |
| [13] | 梁静文, 余卓恒, 刘宜欢, 等. 精神分裂症患者血浆外泌体微小RNA差异表达谱及其生物信息学分析[J]. 临床精神医学杂志, 2023, 33(5):372-376. |
| [14] |
Funahashi Y, Yoshino Y, Iga J I, et al. Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia[J]. World J Biol Psychiatry, 2023, 24(4):303-313.
DOI URL |
| [15] |
Khadimallah I, Jenni R, Cabungcal J H, et al. Mitochondrial,exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons,psychopathology,and neurocognition in schizophrenia[J]. Mol Psychiatry, 2022, 27(2):1192-1204.
DOI |
| [16] |
Singh M, Dwibedy S L L, Biswal S R, et al. Circular RNA:a novel and potential regulator in pathophysiology of schizophrenia[J]. Metab Brain Dis, 2022, 37(5):1309-1316.
DOI |
| [17] |
Tan G, Wang L, Liu Y, et al. The alterations of circular RNA expression in plasma exosomes from patients with schizophrenia[J]. J Cell Physiol, 2021, 236(1):458-467.
DOI URL |
| [18] |
Du X, Hu W, Li X, et al. CircRNA-miRNA-mRNA networks in plasma extracellular vesicles as biomarkers for first-onset schizophrenia[J]. BMC Psychiatry, 2025, 25(1):688.
DOI PMID |
| [19] |
Wu G, Du X, Li Z, et al. The emerging role of long non-coding RNAs in schizophrenia[J]. Front Psychiatry, 2022, 13:995956.
DOI URL |
| [20] |
Guo C, Li J, Guo M, et al. Aberrant expressions of MIAT and PVT1 in serum exosomes of schizophrenia patients[J]. Schizophr Res, 2022, 240:71-72.
DOI URL |
| [21] |
Du X, Lv J, Feng J, et al. Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia[J]. BMC Psychiatry, 2023, 23(1):611.
DOI PMID |
| [22] |
Ni P, Ma Y, Chung S. Mitochondrial dysfunction in psychiatric disorders[J]. Schizophr Res, 2024, 273:62-77.
DOI URL |
| [23] |
Goetzl E J, Srihari V H, Guloksuz S, et al. Neural cell-derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis[J]. FASEB J, 2021, 35(2):e21339.
DOI URL |
| [24] |
Goetzl E J, Srihari V H, Mustapic M, et al. Abnormal levels of mitochondrial Ca2+ channel proteins in plasma neuron-derived extracellular vesicles of early schizophrenia[J]. FASEB J, 2022, 36(8):e22466.
DOI URL |
| [25] |
Xue T, Liu W, Wang L, et al. Extracellular vesicle biomarkers for complement dysfunction in schizophrenia[J]. Brain, 2024, 147(3):1075-1086.
DOI URL |
| [26] |
Lee E E, Winston-gray C, Barlow J W, et al. Plasma levels of neuron- and astrocyte-derived exosomal amyloid beta1- 42,amyloid beta1-40,and phosphorylated Tau levels in schizophrenia patients and non-psychiatric comparison subjects:relationships with cognitive functioning and psychopathology[J]. Front Psychiatry, 2021, 11:532624.
DOI URL |
| [27] |
Vallée A. Neuroinflammation in schizophrenia:the key role of the WNT/β-Catenin pathway[J]. Int J Mol Sci, 2022, 23(5):2810.
DOI URL |
| [28] | 梁静文, 余卓恒, 叶彩虹, 等. 首发精神分裂症相关血浆外泌体蛋白标志物的筛查[J]. 国际精神病学杂志, 2024, 51(1):42-48. |
| [29] |
Ranganathan M, Rahman M, Ganesh S, et al. Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia[J]. World J Biol Psychiatry, 2022, 23(1):33-45.
DOI URL |
| [30] | Zhang S, Liao A, Wang Y, et al. Profiling expressing features of surface proteins on single-exosome in first-episode schizophrenia patients:a preliminary study[J]. Schizophrenia(Heidelb), 2024, 10(1):84. |
| [31] |
Xavier G, Navarrete Santos A, Hartmann C, et al. Comparison of extracellular vesicles from induced pluripotent stem cell-derived brain cells[J]. Int J Mol Sci, 2024, 25(7):3575.
DOI URL |
| [32] |
Zorkina Y, Ushakova V, Ochneva A, et al. Lipids in psychiatric disorders:functional and potential diagnostic role as blood biomarkers[J]. Metabolites, 2024, 14(2):80.
DOI URL |
| [33] |
Del Campo C M Z, Nicolson G L, Sfera A. Neurolipidomics in schizophrenia:a not so well-oiled machine[J]. Neuropharmacology, 2024, 260:110117.
DOI URL |
| [34] |
Du Y, Chen L, Li X S, et al. Metabolomic identification of exosome-derived biomarkers for schizophrenia:a large multicenter study[J]. Schizophr Bull, 2021, 47(3):615-623.
DOI URL |
| [35] |
Xu C X, Huang W, Shi X J, et al. Dysregulation of serum exosomal lipid metabolism in schizophrenia:a biomarker perspective[J]. Mol Neurobiol, 2025, 62(3):3556-3567.
DOI |
| [36] |
Welsh J A, Goberdhan D C I, O'Driscoll L, et al. Minimal information for studies of extracellular vesicles(MISEV2023):from basic to advanced approaches[J]. J Extracell Vesicles, 2024, 13(2):e12404.
DOI URL |
| [37] | Chen W, Gan Z, Qin J. Microfluidic strategies for separation and analysis of circulating exosomes[J]. Se Pu, 2021, 39(9):968-980. |
| [38] |
Desmeules C, Corbeil O, Huot-lavoie M, et al. Psychotic disorders and exosomes:an overview of current evidence and future directions[J]. Psychiatry Res, 2024, 339:116066.
DOI URL |
| [1] | LI Xuemin, LI Xiaocong, DING Haitao. Research progress of exosomes in the early diagnosis of breast cancer [J]. Laboratory Medicine, 2026, 41(9): 922-928. |
| [2] | HE Yiming, WANG Likang, LIU Wenqing, ZHANG Lina. Research progress on long non-coding RNA in the development and progression of gliomas [J]. Laboratory Medicine, 2026, 41(8): 818-823. |
| [3] | WENG Wenhao. Iteration of laboratory diagnostic technologies for colorectal cancer:from early screening optimization to precise monitoring of MRD [J]. Laboratory Medicine, 2026, 41(4): 309-317. |
| [4] | CHEN Xuefei, HUANG Juan, REN Shengjie, MIN Xiangyang, XU Zizhen. Research on the prognostic role of transmembrane protein 205 in patients with colorectal cancer [J]. Laboratory Medicine, 2026, 41(4): 346-354. |
| [5] | LIU Peng, CHANG Zhixin, PENG Lin, QI Dongdong. Preliminary study on the correlation between gut microbiota and metabolomics and schizophrenia [J]. Laboratory Medicine, 2026, 41(4): 374-379. |
| [6] | SHAO Yu, WANG Pin, ZHOU Mo. Role of serum lncRNA HOTTIP and lncRNA HULC expression in multiple myeloma monitoring and prognosis judgement [J]. Laboratory Medicine, 2026, 41(3): 258-264. |
| [7] | LIU Xingxing, YANG Han, YIN Di. Role of preoperative serum lncRNA CDKN2B-AS1 and miR-383-5p in assessing N stage and postoperative recurrence of thyroid cancer [J]. Laboratory Medicine, 2026, 41(2): 163-168. |
| [8] | GUO Manman, ZHANG Peng, WANG Runzhi, SHI Long. Correlation between the expression of serum lncRNA NEAT1,miR-29c-3p and the disease status,clinical prognosis of epilepsy in children [J]. Laboratory Medicine, 2025, 40(8): 763-768. |
| [9] | GAO Xiantong, YAO Qianqian, RU Lijuan. Establishment and clinical application evaluation of early warning model for acute pancreatitis complicated with AKI [J]. Laboratory Medicine, 2025, 40(8): 775-781. |
| [10] | Yueyang Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai University of Traditional Chinese Medicine Shanghai Center for Clinical Laboratory, Clinical Laboratory Society of Chinese Association for Rehabilitation Medicine Clinical Laboratory Society of Chinese Association of Integrative Medicine, Tumor Immunology Branch of Shanghai Society for Immunology Molecular Diagnostics Society of Shanghai Medical Association. Expert consensus on non-invasive laboratory diagnosis for hepatic fibrosis [J]. Laboratory Medicine, 2025, 40(7): 625-641. |
| [11] | YAN Hua, GAO Dahan, LIU Dongfeng. Correlation and clinical significance of serum lncRNA THRIL and miR-495-3p expressions with common intestinal bacterial species in children with inflammatory bowel disease [J]. Laboratory Medicine, 2025, 40(6): 565-570. |
| [12] | WU Yazhou, LI Hanhua, MENG Leijun, CHEN Xuefei, SUN Yuhan, WENG Wenhao, ZHENG Bing. Fusobacterium nucleatum promoting chemoresistance of colorectal cancer cells via lncRNA XIST [J]. Laboratory Medicine, 2025, 40(5): 428-436. |
| [13] | TIAN Ze, LIU Hongrui, SI Wenzhe. Research progress of exosomal miRNA as biomarkers of hepatocellular carcinoma [J]. Laboratory Medicine, 2025, 40(4): 317-323. |
| [14] | CHEN Kun, XU Guowei, WANG Qiuli. Expression changes of plasma lncRNA PINK1-AS and miR-532-5p in patients with ischemic stroke and their effects on sleep quality and cognitive function [J]. Laboratory Medicine, 2025, 40(12): 1203-1208. |
| [15] | CHEN Qiuying, ZHANG Lei, ZHOU Shupei, YAO Miaomiao, WANG Lirong, YIN Haibo, LI Xin. Correlation between serum NRG-1 and MMP-9 levels and cognitive function of patients with stable schizophrenia [J]. Laboratory Medicine, 2025, 40(11): 1091-1096. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||